Disclaimer:
​
Information on this site does not constitute medical advice. Prostate cancer diagnosis and its treatment have serious and possibly life-long consequences. Patients, if possible, are encouraged to seek more than one professional opinion regarding their particular medical situation. It is suggested that patients should research the healthcare professionals.
When asked for recommendations, questions to ask may include:
​
1) The physician’s board certification and license to practice the areas of concern to the patients.
2) How many patients and particularly those who have similar diagnosis and procedures have been treated by the physician and what were the outcomes?
3) Does the physician follow the treatment guidelines by national professional organizations such as CDC, NCCN, NCI, ACS, ASCO, ASTRO, AUA, …? If not, why not?
4) Is the physician aware of latest studies, peer-reviewed reports and clinical trials results and can guide the patients to the optimum treatment modality?
5) Does the physician and their team provide the patient with adequate time to answers to questions?
6) Has the physician been subjected to disciplinary actions by the medical board?
7) Does the patient feel comfortable with the physician’s knowledge, availability, and bedside manner, discussion, meetings, and subsequent follow-up?
The lists of healthcare facilites are evolving and are not endorsements. We do not accept any fees from providers or advertisements from anyone or organizations. These names are submitted by support group members or via public presentations. There is no independent examination of the professional qualifications, education, experience or other credentials of those with whom we have linked, the validity or suitability of the services or products they offer, or of the accuracy of the content of the linked sites. For additional listings of facilities not here, please email to: prostateNOW.org@gmail.com
​
Second Opinion
Johns Hopkins Pathology Johns Hopkins provides 2nd opinion review of prostate cancer biopsy. Or: https://pathology.jhu.edu/patient-care/second-opinions
Memorial Sloan Kettering Cancer Center Second Opinion Review (844) 298 6212
Ming Zhou, MD, Phd Anatomic Pathology and Clinical Pathology, pathological 2nd opinion
Moffitt Cancer Center Florida-based National Cancer Institute-designated Comprehensive Cancer Center focused on cutting-edge research and treatment.
Peter Choyke, MD, FACR Chief of Molecular Imaging Program, National Cancer Institute
www.RockyMountainCancerCenters.com Colorado-based prostate cancer center with options for second opinion either in-person or virtually
www.tuftsmedicalCenter.org/physicianDirectory/ming-zhou Second review of prostate cancer pathology is available
List of Prostate Cancer physicians
Other Resources
Active Surveillance Patients International co-founded by Howard Wolinsky, engages with science-based professionals in updating our AS protocols.
AnCan.org is about people helping people who are living with various medical conditions including prostate cancer
Artera.Ai provides multimodal AI test for individualized results and treatment decision-making between clinicians and patients
AS 101 is a series of conversations between actual patients with their partners/spouses and leading prostate physicians
Cancer.gov is part of the National Institute of Health. It has many free Prostate Cancer documents
Decipher used to determine how likely the patient's cancer is to metastasize within the next five years.
Drug Interaction Checker from WebMD
Glossary of Prostate Cancer from UCSF Health
Grand Rounds in Urology provides Education in Urology
MDX improves the detection of aggressive prostate cancer and urologic diseases with personalized molecular diagnostic solutions
Micro-Ultrasound physician finder to locate a urology practice with an EXACTVU Micro-Ultrasound system
National Alliance of State Prostate Cancer Coalitions features quarterly Prostatepedia Magazine to tackle a different topic facing prostate cancer patients today.
NCCN.org National Comprehensive Cancer Network has many free Prostate Cancer documents
NCI-Designated Cancer Center NCI-Designated Centers-of-Excellence to deliver cutting-edge cancer treatments to patients in communities across the USA.
NLM NCBI (National Library of Medicine, National Center for BioTechnology Info.) Table 1 Treatment Selection for Localized Prostate Cancer; Stratified by Risk Group. Oct 29, 2020
Nomograms at following URLs:
https://www.mskcc.org/nomograms/prostate - https://prostatecancerinfolink.net/tips-tools/kattan-nomograms/ https://www.hopkinsmedicine.org/brady-urology-institute/conditions_and_treatments/prostate_cancer/risk_assessment_tools/partin-nomograms.html
https://www.uclahealth.org/medical-services/nuclear-medicine/research/prostate-cancer-nomogram
https://urology.ucsf.edu/research/cancer/prostate-cancer-risk-assessment-and-the-ucsf-capra-score
Oncotype DX is a test that measures activity of certain genes from biopsy tissue and reports it a score on a scale from 0 to 100
Precision Point Transperineal Biopsy
Prolaris advanced genetic test to determine how aggressive your prostate cancer is
Prostate Cancer Free Foundation * Your opportunity to compare prostate cancer treatments.
Prostate Cancer News Authored by Allen Edel, a patient advocate writing regular column for the New Prostate Cancer Infolink and other publications.
Prostate News and Development (Updated 01/06/2024) Recent news, development of Prostate Cancer management
Prostate Cancer Promise.org/ Your DNA may be the most powerful tool to fight Prostate Cancer
Prostate Oncology Specialists Specialized prostate physicians to help identifying, supervising and managing all stages of the disease
PSMA-target PET GA-68, First PSMA-11 FDA-approved for prsotate cancer imaging indications
Pubmed.ncbi.nlm.nih.gov is part of the National Institute of Health with many peer-reviewed abstracts, documents on Prostate Cancer
Pylarify (piflufolastat F 18) – second FDA-approved drug for PSMA/PET (positron emission tomography) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer.
Transperineal vs Precision Point biopsy Youtube video discussing Precision Point transperineal biopsy
The Active Surveillor Prostate Cancer newsletters by Howard Wolinksy
The Reluctant Brotherhood provides a safe space where men and their partners can openly share their experiences and feelings without fear of jusgment
Uro Today Partnering with the PCF, Powering Education Driven by Evidence
Urology Times publishes various articles with many related to prostate cancer diagnosis and treatments
​
​
Click here for more ....